NUCALA

100MG INJ PLV SOL 3

SÚKL code 0209058
Name of the product NUCALA
_MA_MEDICATION_DETAIL_INFO_MED_NAME i NUCALA
Supplement 100MG INJ PLV SOL 3
Strenght 100MG
Pharmaceutical form Powder for solution for injection
Package 3
Route Subcutaneous use
Wrap type Vial
Legal status na lékařský předpis
Active substance MEPOLIZUMAB (MEPOLIZUMABUM)
ATC group R03DX09
ATC group name MEPOLIZUMAB

Marketing authorisation information

Registration Number EU/1/15/1043/002
Type of MA centralised without orphans
MA status R - active MA/authorised medicinal product
MA Holder GlaxoSmithKline Trading Services Limited, Dublin
MA Holder country IRSKO

Back to list